1. Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens including a pharmacokinetically enhanced formulation 
E. Löwdin, O. Cars, I. Odenholt 
Clinical Microbiology and Infection 
Volume 8, Issue 10, Pages (October 2002)
DOI: /j x
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

2. Figure 1
The concentration of amoxicillin in the in vitro kinetic model corresponding to a dose of 875 mg b.i.d. (♦), 500 mg t.i.d. (▪) and of the pharmacokinetically enhanced formulation 2000 mg b.i.d. (▴).
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

3. Figure 2
The rate and extent of killing of amoxicillin/clavulanic acid at a concentration corresponding to a dose of 875/125 mg b.i.d. (▪) and 500/125 mg t.i.d. (♦) against H. influenzae LH 2803 in the in vitro kinetic model (mean ± SD).
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

4. Figure 3
(a) The rate and extent of killing of amoxicillin/clavulanic acid at a concentration corresponding to a dose of 875/125 mg b.i.d. against the clinical strains of H. influenzae in the in vitro kinetic model (mean ± SD). (b) The rate and extent of killing of amoxicillin/clavulanic acid at a concentration corresponding to a dose of 500/125 mg t.i.d. against the clinical strains of H. influenzae in the in vitro kinetic model.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

5. Figure 4
The rate and extent of killing of amoxicillin/clavulanic acid simulating the slow-release compound against H. influenzae LH 2803 and the clinical strains of H. influenzae in the in vitro kinetic model (mean ± SD).
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions